Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v1-EN
Language English English
Date Updated 2022-10-05 2022-04-21
Drug Identification Number 02238162 02238162
Brand name DIASTAT DIASTAT
Common or Proper name DIASTAT DIASTAT
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients DIAZEPAM DIAZEPAM
Strength(s) 5MG 5MG
Dosage form(s) GEL GEL
Route of administration RECTAL RECTAL RECTAL RECTAL
Packaging size 5mg/2pk 5mg/2pk
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2022-04-25 2022-04-25
Actual start date 2022-04-22
Estimated end date 2022-11-30 2022-06-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments